| Inflammatory Bowel Disease |
1 |
1 |
| Colitis |
0 |
0.62 |
| Crohn Disease |
0 |
0.5 |
| Biologic Therapy |
0 |
0.4 |
| Ulcerative Colitis |
0 |
0.39 |
| Epidemiology |
0 |
0.31 |
| Hospital |
0 |
0.31 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.29 |
| Topical Corticosteroid |
0 |
0.22 |
| Clinical Guidelines |
0 |
0.2 |
| Corticosteroids |
0 |
0.2 |
| Tumor |
0 |
0.2 |
| Biomarker |
0 |
0.1 |
| Brain |
0 |
0.1 |
| Child |
0 |
0.1 |
| Europe |
0 |
0.1 |
| Fatigue |
0 |
0.1 |
| Fistulizing Crohn Disease |
0 |
0.1 |
| Immunomodulator |
0 |
0.1 |
| Interleukin |
0 |
0.1 |
| Microbicides |
0 |
0.1 |
| Quality of Life |
0 |
0.1 |
| Receptors |
0 |
0.1 |
| Refractory |
0 |
0.1 |
| Surgery |
0 |
0.1 |
| Therapeutic Drug Monitoring |
0 |
0.1 |
| Young Adult |
0 |
0.1 |
| Stem Cell Research and Therapy |
0 |
0.05 |